Gross P A, Quinnan G V, Rodstein M, LaMontagne J R, Kaslow R A, Saah A J, Wallenstein S, Neufeld R, Denning C, Gaerlan P
Department of Internal Medicine, Hackensack Medical Center, NJ 07601.
Arch Intern Med. 1988 Mar;148(3):562-5.
We prospectively studied the efficacy of influenza vaccine during an influenza A/Arizona/80 (H3N2) outbreak at the Jewish Home and Hospital for the Aged in New York in the winter season of 1982 to 1983. All patients had been offered influenza vaccine before the outbreak; 181 chose to be vaccinated and 124 refused vaccination but agreed to participate in the study. Among those with serologic evidence of influenza infection, respiratory illness was significantly more common in the unvaccinated group (six of 14 vs one of 22). The overall mortality was 13 (7.2%) of 181 in the vaccinated group and 22 (17.7%) of 124 in the control group. The vaccinated and the control groups were examined for comparability. A logistic regression analysis, which controlled for differences in sex and level of nursing care, indicated that the difference in mortality was still significant, with a summary odds ratio of 2.7. The relative risk of death in the unvaccinated group was comparable at 2.18. Influenza vaccine reduced the mortality by 59% in the vaccinated group compared with the control group.
我们前瞻性地研究了1982年至1983年冬季纽约犹太老人之家和医院甲型流感/亚利桑那/80(H3N2)疫情期间流感疫苗的疗效。在疫情爆发前,所有患者都被提供了流感疫苗;181人选择接种疫苗,124人拒绝接种但同意参与研究。在有流感感染血清学证据的人群中,未接种疫苗组的呼吸道疾病明显更为常见(14人中有6人,而22人中有1人)。接种疫苗组181人中的总死亡率为13人(7.2%),对照组124人中的总死亡率为22人(17.7%)。对接种疫苗组和对照组进行了可比性检查。一项控制了性别和护理水平差异的逻辑回归分析表明,死亡率差异仍然显著,汇总比值比为2.7。未接种疫苗组的相对死亡风险相当,为2.18。与对照组相比,接种疫苗组的流感疫苗使死亡率降低了59%。